Clareo Health | Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer
Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rutgers, The State University of New Jersey
With
National Cancer Institute (NCI)
National Institutes of Health (NIH)
PRIMARY OBJECTIVES:
I. Develop the EXCELS intervention to facilitate engaged self-management of cancer follow-up for cancer survivors.
II. Evaluate the efficacy of EXCELS intervention in a small randomized controlled trial.
III. Assess/refine intervention usability and acceptability for primary care patients.
OUTLINE:
PHASE I: EXCELS intervention is developed and assessed.
PHASE II: Participants are randomized into 1 of 4 arms.
ARM I: Participants receive National Cancer Institute's Facing Forward brochure.
ARM II: Participants have untimed access to the EXCELS mobile web application.
ARM III: Participants also receive 4 calls of 15-20 minutes each over 3 months focusing on assisting survivors with addressing challenges to receiving preventive service and health care.
ARM IV: Participants have access to EXCELS website as in Arm II. Participants also receive 4 health coaching calls as in Arm III.
Patients are followed up at 6 months, 12 months and 18 months post randomization.
Age
30–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have been diagnosed with localized breast or prostate (stages 1-2) or colorectal cancer (stage 1-3)
Have completed active treatment for their cancer diagnosis (excluding hormonal therapy)
Have access to a phone for contact with health coach
Be able to communicate in English; and be competent to consent
Usability Testing and the randomized control trial (RCT): have access to a computer, a smartphone or an i-Pad/tablet equivalent with internet access
You may not be if
Patients who are required because of their disease to see primarily oncologists for follow-up will be excluded (i.e., those diagnosed with lymph node or distant metastasis, those with a new primary cancer)
